RENAISSANCE TECHNOLOGIES LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1037389
NEW YORK, NY
Position in HALO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$47,296,944
+$9,426,494 QoQ
Shares Held
731,811
+30.1% QoQ
Ownership
0.617%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. HALO ranks #14 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in HALO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,296,944 | 731,811 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $37,870,450 | 562,711 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $73,355,328 | 1,000,209 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $17,614,440 | 338,609 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,657,838 | 120,010 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,248,319 | 26,110 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,612,227 | 255,280 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $19,770,088 | 377,580 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $17,548,538 | 431,380 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,147,324 | 193,380 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,036,976 | 105,680 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,229,265 | 34,080 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,633,434 | 95,141 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,059,372 | 141,641 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,167,182 | 358,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,348,800 | 485,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,283,076 | 207,700 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,066,460 | 126,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,232,176 | 153,200 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $28,086,553 | 673,700 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $22,556,389 | 528,129 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $13,867,956 | 527,700 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $27,029,842 | 1,008,200 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,817,966 | 323,400 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||